Improved radiotracing of oxytocin receptor-expressing tumours using the new [(111)In]-DOTA-Lys(8)-deamino-vasotocin analogue

por Chini, B, Chinol, M, Cassoni, P, Papi, S, Reversi, A, Areces, L, Marrocco, T, Paganelli, G, Manning, M, Bussolati, G
Publicado 2003

Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study

por Grana, C, Chinol, M, Robertson, C, Mazzetta, C, Bartolomei, M, De Cicco, C, Fiorenza, M, Gatti, M, Caliceti, P, Paganelli, G
Publicado 2002

Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity.

por Chinol, M., Casalini, P., Maggiolo, M., Canevari, S., Omodeo, E. S., Caliceti, P., Veronese, F. M., Cremonesi, M., Chiolerio, F., Nardone, E., Siccardi, A. G., Paganelli, G.
Publicado 1998

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT(R))

por De Santis, R, Anastasi, A M, D'Alessio, V, Pelliccia, A, Albertoni, C, Rosi, A, Leoni, B, Lindstedt, R, Petronzelli, F, Dani, M, Verdoliva, A, Ippolito, A, Campanile, N, Manfredi, V, Esposito, A, Cassani, G, Chinol, M, Paganelli, G, Carminati, P
Publicado 2003